Maze Therapeutics Inc (MAZE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | 52,231 | -100,415 | -114,940 |
| Depreciation Amortization | 3,297 | 4,089 | 3,820 |
| Accounts payable and accrued liabilities | -204 | 399 | -3,777 |
| Other Working Capital | -1,523 | -6,316 | -3,236 |
| Other Operating Activity | 22,153 | 15,416 | 18,930 |
| Operating Cash Flow | $75,954 | $-86,827 | $-99,203 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -1,147 | -441 | -1,966 |
| Other Investing Activity | 0 | 0 | -1,204 |
| Investing Cash Flow | $-1,147 | $-441 | $-3,170 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 24,475 | 16,176 | N/A |
| Common Stock Issued | 733 | 209 | 154 |
| Other Financing Activity | 67,639 | 0 | 1,574 |
| Financing Cash Flow | $92,847 | $16,385 | $1,728 |
| Beginning Cash Position | 30,246 | 101,129 | 201,774 |
| End Cash Position | 197,900 | 30,246 | 101,129 |
| Net Cash Flow | $167,654 | $-70,883 | $-100,645 |
| Free Cash Flow | |||
| Operating Cash Flow | 75,954 | -86,827 | -99,203 |
| Capital Expenditure | -1,147 | -441 | -1,966 |
| Free Cash Flow | 74,807 | -87,268 | -101,169 |